Table 1 Characteristics of the study population stratified by chelation therapy
Group 1 (N = 93) | Group 2 (N = 65) | P value | |
|---|---|---|---|
Age (years) | 24.47 ± 8.00 | 26.93 ± 8.16 | 0.062 |
Female (n, %) | 33 (35.5%) | 32 (49.2%) | 0.084 |
Time since first symptoms (months) | 24 (3–60) | 23 (3–96) | 0.748 |
Psychiatric symptoms (n, %) | 5 (5.4%) | 4 (6.1%) | 0.836 |
Hepatic dysfunction at diagnosis (n, %) | 23 (24.7%) | 19 (29.2%) | 0.529 |
Kayser-Fleischer corneal rings (n, %) | 93 (100%) | 65 (100%) | |
Serum ceruloplasmin (< 200 mg/L) | 93 (100%) | 65 (100%) | |
Abnormal brain MRI (n, %) | 93 (100%) | 65 (100%) |